Why is Nectar Lifesci. falling/rising?

As of 09-Jul, Nectar Lifescience Ltd is experiencing a decline in its stock price, currently at Rs 16.47, which reflects a decrease of Rs 2.06 or 11.12%. The stock has hit a new 52-week low of Rs 15.61 today and has underperformed its sector by 11.32%. Over the past week, the stock has fallen by 28.11%, and its year-to-date performance shows a significant decline of 57.77%. The company is facing substantial operating losses, with a negative EBITDA and a high debt-to-EBITDA ratio of 5.71 times, indicating weak long-term fundamental strength. Additionally, 99.6% of promoter shares are pledged, which adds downward pressure on the stock price in a falling market.
In the broader market context, while the Sensex has shown a slight increase of 0.15% over the past week, Nectar Lifescience's performance starkly contrasts this trend, highlighting its struggles. The stock's significant underperformance relative to the benchmark is evident, with a 30.39% decline over the past month compared to a 1.32% rise in the Sensex. This disparity underscores the challenges faced by the company, including a drastic fall in profit after tax and low return on equity, which collectively contribute to the stock's negative momentum.